| 1 |
31344002 | Treatment With Cyclosporine A for Statin-Naïve Anti-HMGCR Antibody-Associated Necrotizing Myopathy. | 2019 Aug |
1 |
| 2 |
15989499 | The effect of HMG-CoA reductase inhibitors on chronic allograft rejection. | 2001 Apr |
1 |
| 3 |
10070171 | In vitro effects of simvastatin on tubulointerstitial cells in a human model of cyclosporin nephrotoxicity. | 1999 Mar |
1 |
| 4 |
10573315 | Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine. | 1999 Nov |
1 |
| 5 |
9808867 | The continuing challenge of cardiac transplant arteriosclerosis. | 1998 Aug |
1 |
| 6 |
9096609 | Reversal of cyclosporine-inhibited low-density lipoprotein receptor activity in HepG2 cells by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. | 1997 Apr |
1 |
| 7 |
9328321 | Additive inhibitory effect of hydrocortisone and cyclosporine on low-density lipoprotein receptor activity in cultured HepG2 cells. | 1997 Oct |
1 |
| 8 |
18020528 | Use of HMG-CoA Reductase Inhibitors after Kidney and Heart Transplantation: Lipid-Lowering and Immunosuppressive Effects. | 1997 Nov |
1 |
| 9 |
8970607 | Evaluation of fluvastatin in the treatment of hypercholesterolemia in renal transplant recipients taking cyclosporine. | 1996 Dec 15 |
1 |
| 10 |
7604782 | A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine. | 1995 Jul 13 |
1 |
| 11 |
8343198 | Clinical pharmacokinetics and practical applications of simvastatin. | 1993 Mar |
1 |